Name | tert-butyl N-(5-tributylstannyl-1,3-thiazol-2-yl)carbamate |
---|---|
Synonyms |
Carbamic acid, N-[5-(tributylstannyl)-2-thiazolyl]-, 1,1-dimethylethyl ester
tert-Butyl [5-(tributylstannyl)-1,3-thiazol-2-yl]carbamate (5-tributylstannyl-thiazol-2-yl)-carbamic acid tert-butyl ester tert-butyl 5-(tributylstannyl)thiazol-2-ylcarbamate 2-(N-BOC)-5-(tributylstannyl)thiazole 2-Amino-5-(tributylstannyl)-1,3-thiazole, 2-BOC protected 2-Methyl-2-propanyl [5-(tributylstannyl)-1,3-thiazol-2-yl]carbamate tert-Butyl-5-(tributylstannyl)thiazol-2-ylcarbamate (N-Boc-2-aminothiazolo)tributyltin |
Molecular Formula | C20H38N2O2SSn |
---|---|
Molecular Weight | 489.303 |
Exact Mass | 490.167603 |
PSA | 79.46000 |
LogP | 9.67 |
Storage condition | 2~8℃ |
Symbol |
GHS06, GHS08, GHS09 |
---|---|
Signal Word | Danger |
Hazard Statements | H301-H312-H315-H319-H372-H410 |
Precautionary Statements | P273-P280-P301 + P310-P305 + P351 + P338-P314-P501 |
RIDADR | UN 3146 6.1 / PGIII |
HS Code | 2934100090 |
~90% 243972-26-1 |
Literature: SPHAERA PHARMA PVT. LTD.; DUGAR, Sundeep; MAHAJAN, Dinesh; HOLLINGER PETER, Frank; SHARMA, Amit; TRIPATHI, Vinayak; KUILA, Bilash Patent: WO2014/16849 A2, 2014 ; Location in patent: Page/Page column 121; 122 ; |
~80% 243972-26-1 |
Literature: AMGEN INC. Patent: US2007/173506 A1, 2007 ; Location in patent: Page/Page column 54; 55 ; |
~% 243972-26-1 |
Literature: WO2014/16849 A2, ; |
Precursor 3 | |
---|---|
DownStream 0 |
HS Code | 2934100090 |
---|---|
Summary | 2934100090 other compounds containing an unfused thiazole ring (whether or not hydrogenated) in the structure VAT:17.0% Tax rebate rate:9.0% Supervision conditions:none MFN tariff:6.5% General tariff:20.0% |